Brief: Targovax: Presentation Of Pre-Clinical Data From Next Generation ONCOS At AACR Virtual Annual Conference
June 24 (Reuters) - Targovax ASA TRVX.OL :
* TARGOVAX ANNOUNCES PRESENTATION OF PRE-CLINICAL DATA FROM
NEXT
GENERATION ONCOS AT AACR VIRTUAL ANNUAL CONFERENCE
* PRE-CLINICAL IN VITRO AND IN VIVO FINDINGS DEMONSTRATED
THAT
BOTH ONCOS-210 & ONCOS-212 HAVE ANTI-CANCER PROPERTIES AND THAT
DOUBLE TRANSGENES ACT SYNERGISTICALLY
Source text for Eikon: ID:nWkr23CDWw
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration